FDA Announces Coronavirus-Related Drug Shortage

The video discusses the impact of the coronavirus outbreak on drug shortages in the US. FDA Commissioner Stephen Hahn announced a shortage of a human drug due to manufacturing issues linked to coronavirus-affected sites. The FDA has contacted over 180 manufacturers to ensure they report any supply disruptions. Approximately 20 drugs have active ingredients or finished products sourced solely from China, raising concerns about supply chain stability. Additionally, six manufacturers of animal drugs have reported potential shortages. Patients are advised to consult their doctors for alternatives if concerned about specific drugs.

What was the reason given for the shortage of a human drug as announced by the FDA commissioner?

• Regulatory changes in drug approval

• Lack of raw materials from Europe

• Manufacturing issues at a site affected by coronavirus

• Increased demand due to the coronavirus outbreak

What action has the FDA taken since January 24th to address potential drug shortages?

• Increased drug imports from Europe

• Contacted over 180 manufacturers to remind them of notification requirements

• Reduced drug prices to increase availability

• Partnered with local pharmacies to stockpile drugs

How many drugs did the FDA identify as having active ingredients or finished products solely sourced from China?

• 10

• 15

• 20

• 25

What is the concern for manufacturers of animal drugs according to the transcript?

• New regulations on animal drug testing

• Increased competition from international markets

• Decreased demand for animal drugs

• Disruptions in the supply chain leading to potential shortages

What should patients do if they are worried about a specific drug shortage?

• Contact the drug manufacturer directly

• Switch to herbal remedies

• Discuss alternatives with their doctor

• Stockpile the drug at home